Eugene D Mead, MD | |
275 11th St S, Wahpeton, ND 58075-4655 | |
(701) 642-2000 | |
(701) 671-4106 |
Full Name | Eugene D Mead |
---|---|
Gender | Male |
Speciality | Obstetrics & Gynecology |
Location | 275 11th St S, Wahpeton, North Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831134204 | NPI | - | NPPES |
0704470 | Other | ND | MEDICA # |
322S6ME | Other | ND | MNBS # |
7714940 | Medicaid | ND | |
44941 | Other | ND | LHS # |
11668 | Medicaid | ND | |
063H8ME | Other | ND | MNBS # |
140851 | Other | ND | UCARE # |
25882 | Other | ND | NDBS # |
26679 | Other | ND | NDBS # |
DA9051029487 | Other | ND | PREFERRED ONE # |
063H9ME | Other | ND | MNBS # |
0704719 | Other | ND | MEDICA # |
26507 | Other | ND | NDBS # |
449007000 | Medicaid | ND | |
HP54455 | Other | ND | HEALTHPARTNERS # |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 6079 (North Dakota) | Primary |
207V00000X | Obstetrics & Gynecology | 47985 (Minnesota) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Eugene D Mead, MD 275 11th St S, Wahpeton, ND 58075-4655 Ph: (701) 642-2000 | Eugene D Mead, MD 275 11th St S, Wahpeton, ND 58075-4655 Ph: (701) 642-2000 |
News Archive
A means of reprogramming a flawed immune response into an efficient anti-tumoral one was brought to light by the results of a translational trial relating to breast cancer. Thanks to the innovative combination of mathematical modelisation and experimentation, only 20 tests were necessary, whereas traditional experimentation would have required 596 tests to obtain the same results.
Aeolus Pharmaceuticals, Inc. reported that researchers from National Jewish Health and McGill University have completed a series of preliminary studies demonstrating that AEOL 10150 protects lungs from chlorine gas exposure in mice.
Within a few weeks, perhaps before many Americans finish decorating for the holidays, the U.S. could have access to a new antiviral pill from Merck expected to alter the deadly trajectory of the covid-19 pandemic — with a second option from Pfizer to follow shortly after.
As our environments change over time with technology, pediatric emergency specialists are continuously challenged to observe possible trends and prevent more injuries by educating the public.
"Changing attitudes about pediatric vaccination can be challenging," says Dr. Kumanan Wilson, professor of medicine and health policy, management and evaluation at U of T, internal medicine physician at Toronto General Hospital, University Health Network, and lead author of the research.
› Verified 2 days ago